当前位置:首页 - 行情中心 - 东北制药(000597) - 财务分析 - 现金流量表

东北制药

(000597)

  

流通市值:67.08亿  总市值:67.92亿
流通股本:14.09亿   总股本:14.27亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,043,537,931.821,270,748,871.686,913,916,435.175,261,722,047.38
  收到的税费返还10,329,018.376,617,431.3611,357,802.869,727,598.09
  收到其他与经营活动有关的现金149,778,490.0591,729,708.51425,414,903.79173,056,766.13
  经营活动现金流入小计3,203,645,440.241,369,096,011.557,350,689,141.825,444,506,411.6
  购买商品、接受劳务支付的现金1,825,790,035.32781,073,794.243,540,793,039.932,969,341,549.87
  支付给职工以及为职工支付的现金453,417,420.28244,953,803.81,005,729,405.15775,199,096.99
  支付的各项税费214,511,912.8690,983,114.63412,938,190.33318,031,496.56
  支付其他与经营活动有关的现金783,889,317.23235,196,440.751,284,846,025.141,002,731,544.23
  经营活动现金流出小计3,277,608,685.691,352,207,153.426,244,306,660.555,065,303,687.65
  经营活动产生的现金流量净额-73,963,245.4516,888,858.131,106,382,481.27379,202,723.95
二、投资活动产生的现金流量:
  收回投资收到的现金7,000,0007,000,00053,156,000.17-
  取得投资收益收到的现金435,972.22435,972.22--
  处置固定资产、无形资产和其他长期资产收回的现金净额3,558,204.791,504,4005,555,604.81,170,604.8
  投资活动现金流入小计10,994,177.018,940,372.2258,711,604.971,170,604.8
  购建固定资产、无形资产和其他长期资产支付的现金31,193,040.9618,076,797.4997,784,716.4861,590,908.34
  投资支付的现金237,000,000237,000,00050,293,508.78-
  支付其他与投资活动有关的现金---14,000,000
  投资活动现金流出小计268,193,040.96255,076,797.49148,078,225.2675,590,908.34
  投资活动产生的现金流量净额-257,198,863.95-246,136,425.27-89,366,620.29-74,420,303.54
三、筹资活动产生的现金流量:
  吸收投资收到的现金--7,000-
  其中:子公司吸收少数股东投资收到的现金--7,000-
  取得借款收到的现金1,525,000,000430,000,0002,847,800,0002,028,800,000
  收到其他与筹资活动有关的现金2,131,700,000727,850,0003,665,920,0007,322,677,799.16
  筹资活动现金流入小计3,656,700,0001,157,850,0006,513,727,0009,351,477,799.16
  偿还债务支付的现金1,769,600,000650,800,0002,334,000,0001,777,250,000
  分配股利、利润或偿付利息支付的现金98,405,666.511,239,235.73196,902,896.73206,153,565.68
  支付其他与筹资活动有关的现金1,534,750,799.25253,950,397.594,221,774,037.377,300,720,815.8
  筹资活动现金流出小计3,402,756,465.75915,989,633.326,752,676,934.19,284,124,381.48
  筹资活动产生的现金流量净额253,943,534.25241,860,366.68-238,949,934.167,353,417.68
四、汇率变动对现金及现金等价物的影响-27,150,677.62-21,314,318.66-23,810,422.88-8,550,203.22
五、现金及现金等价物净增加额-104,369,252.77-8,701,519.12754,255,504363,585,634.87
  加:期初现金及现金等价物余额2,852,247,107.942,852,247,107.942,097,991,603.942,097,991,603.94
  期末现金及现金等价物余额2,747,877,855.172,843,545,588.822,852,247,107.942,461,577,238.81
补充资料:
  净利润63,804,739.28-217,828,151.01-
  资产减值准备75,182,519.83-175,397,280.07-
  固定资产和投资性房地产折旧210,788,069.55-467,425,909.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧210,788,069.55-467,425,909.79-
  无形资产摊销27,140,137.97-49,657,027.75-
  长期待摊费用摊销3,831,300.54-7,766,864.55-
  处置固定资产、无形资产和其他长期资产的损失-413,486.39--255,861.15-
  固定资产报废损失---797,887.48-
  公允价值变动损失---350,622.31-
  财务费用53,555,584.82-92,435,882.47-
  投资损失-247,183.35--7,809,974.98-
  递延所得税421,859.46--8,273,369.98-
  其中:递延所得税资产减少-101,705.72--6,264,453.48-
    递延所得税负债增加523,565.18--2,008,916.5-
  存货的减少-159,036,899.63-99,692,436.47-
  经营性应收项目的减少-560,222,529.46-101,579,510.12-
  经营性应付项目的增加199,471,686.29--112,792,033.12-
  其他-106,048.39--115,356.38-
  现金的期末余额2,747,877,855.17-2,852,247,107.94-
  减:现金的期初余额2,852,247,107.94-2,097,991,603.94-
  现金及现金等价物的净增加额-104,369,252.77-754,255,504-
公告日期2026-08-252026-04-282026-04-032025-10-28
审计意见(境内)标准无保留意见
TOP↑